Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Articles
DOI: 10.54448/ijn2136
Submitted: 11-01-2021
Published: 11-05-2021

The benefits of glutamine in the treatment of patients with cancer

Federal University of Maranhão, General Surgery and Medical Clinic, São Luís, Maranhão, Brazil
University of Pernambuco, Recife, Brazil
Etianne Bartz Institute, Fortaleza, Ceará, Brazil
Porto Velho Hospital, Rondônia, Brazil
State University of Pará, Brazil
Medical Diagnostics Center, São Luís, Maranhão, Brazil
Immunomodulation Glutamine Amino Acid Cancer Treatment

Abstract

The subject of this study is the benefits of immunonutrition or immunomodulation, based on the concept that malnutrition impairs immune function. It is a therapeutic approach in an artificial form of food with the function of rebuilding cells for the immune response, which involves specific amino acids such as arginine, glutamine, and fiber. In this sense, it is intended to deal specifically with glutamine, which is a “conditionally essential” amino acid, as its concentration in plasma can decrease by up to 50% during stress, causing a deficiency condition. In the treatment of cancer patients, glutamine constitutes an immunomodulatory nutrient, being a fundamental substrate for the cells of the immune system, stimulating the multiplication of lymphocytes, the differentiation of B cells, the production of interleukin 1, and the phagocytosis of macrophages. The high use of glutamine by lymphocytes and macrophages suggests that the provision of this amino acid is of paramount importance for the functioning of these cells and also for the proper functioning of the immune response. Important in viral infections and in combating tumor cells, Natural Killer (NK) cells are dependent on adequate glutamine stores for their proliferation. It also exerts a local immunostimulating effect, increasing intestinal T cells, and is a precursor of an important intracellular antioxidant, glutathione. This is bibliographical research, of a qualitative nature, carried out through specialized scientific articles on the chosen topic.

Metrics

Metrics Loading ...

References

  1. Instituto Nacional de Câncer do Brasil. Estimativa 2010: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2010.
  2. Edwards DN, Ngwa VM, Raybuck AL, Wang S, Hwang Y, Kim LC, Cho SH, Paik Y, Wang Q, Zhang S, Manning HC, Rathmell JC, Cook RS, Boothby MR, Chen J. Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. J Clin Invest. 2021 Feb 15;131(4):e140100. doi: 10.1172/JCI140100. PMID: 33320840; PMCID: PMC7880417.
  3. Leandro-Merhi VA. et al. Estudo comparativo de indicadores nutricionais em pacientes com neoplasias do trato digestório. Arquivos brasileiros de cirurgia digestiva, v. 21, n. 3, p. 114-119, 2008.
  4. Hallay J. et al. Changes in nutritional state and immune-serological parameters of esophagectomized patients fed jejunely with glutamine-poor and glutamine-rich nutriments. Hepato-Gastroenterology, v. 49, n. 4, p. 1555-1559,2002.
  5. Mero A, Leikas A, Knuutinen J, Hulmi JJ, Kovanen V. Effect of strength training session on plasma amino acid concentration following oral ingestion of leucine, BCAAs or glutamine in men. Eur J Appl Physiol. 2009 Jan;105(2):215-23.
  6. Boligon CS, Huth A. O impacto do uso de glutamina em pacientes com tumores de cabeça e pescoço em tratamento radioterápico e quimioterápico. Rev. Bras. Cancerol. Rio de Janeiro, v. 57, n. 1, p. 31 – 38, 2010.
  7. Masisi BK, El Ansari R, Alfarsi L, Rakha EA, Green AR, Craze ML. The role of glutaminase in cancer. Histopathology. 2020 Mar;76(4):498-508. doi: 10.1111/his.14014. Epub 2020 Feb 18. PMID: 31596504.
  8. Cruzat VF, Petry ER, Tirapegui J. Glutamina: Aspectos Bioquímicos, Metabólicos, Moleculares e Suplementação. Rev. Bras, Med. Esporte. 2009, v.15, n. 5, p.392-397.
  9. Curi R, Lagranha CJ, Doi SQ, Sellitti DF, Procopio J, Pithon-Curi TC et al. Molecular mechanisms of glutamine action. J Cell Physiol 2005; 204:392–401.
  10. Arias J. et al. Oxidative stress parameters in women with breast cancer undergoing neoadjuvant chemotherapy and treated with nutraceutical doses of oral glutamie. Acta Cirúrgica Brasileira, São Paulo, Suppl. 1), v. 26, p. 82-87, 2011.
  11. D‟Souza R, Tuck JP. Glutamine supplements in the critically ill. J Royal Soc Med. 2004; 97:425-7.
  12. Berk L. et al. A randomized, double-blind, placebocontrolled trial of a beta- hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia. Support Care Cancer, v. 16, n. 10, p. 1179-1188, abr./ out., 2008.
  13. Kim H. Glutamine as an immunonutrient.Yonsei Med J. 2011; 52(6):892-897.
  14. Novelli M, Strufaldi MB, Rogero MM, Rossi L. Suplementação de Glutamina Aplicada à Atividade Física. R. bras Ci e Mov. 2007; 15(1): 109-117.
  15. Rowbottom DG, Keast D, Morton AR. The emerging role of glutamine as an indicator of exercise stress and overtraining. Sports Med. 1996;31:80-97.
  16. Cetinbas F, Yelken B, Gulbas Z. Role of glutamine administration on cellular immunity after total parenteral nutrition enriched with glutamine in patients with systemic inflammatory response syndrome. Journal of Critical Care. In Press 2010.
  17. Coventry BJ, Ashdown ML. Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation. Cancer Management and Research. 2012 Mai 26;4:137-149.
  18. Dong GL. et al. Effect of alanyl-glutamine on the clinical outcome of patients after total gastrectomy. Chinese Journal of Clinical Nutrition, v. 16, n. 2, p.70-73, jun./out., 2008.
  19. Lobo DL. et al. Early postoperative jejunostomy feeding with an immune modulating diet in patients undergoing resectional surgery for upper gastrointestinal cancer: a estudos, Goiânia, v. 41, n. 2, p. 215-222, 1br./jun. 2014.
  20. Garófolo A, Petrilli AS. Balanço entre ácidos graxos ômega 3 e 6 na resposta inflamatória em pacientes com câncer e caquexia. Revista de Nutrição, Campinas, v. 19, n. 5, p. 611-621, set./out., 2006.
  21. Chen R. et al. Effect of immuneenhanced enteral diet on postoperative immunological function in patients with colorectal cancer. Zhonghua Wei Chang WaiKeZaZhi, v. 8, n. 4, p. 328-330, jul./out., 2005.
  22. Boligon C, Hulth A. O impacto do uso de glutamina em pacientes com tumores de cabeça e pescoço em tratamento radioterápico e quimioterápico. Revista Brasileira de Cancerologia, v. 57, n. 1, p. 31-8, set./nov. 2011 apud KAADIGE, M.R. et al. Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating Mondo A transcriptional activity. Proceedings of the National Academy of Sciences, v. 106, n. 35, p. 12878-12883. fev./jul., 2009.
  23. Salles MJC, Sprovieri RSR, Bedrikow R, Pereira AC, Cardenuto SL, Azevedo PRC, et al. Síndrome da resposta inflamatória sistêmica/sepse - revisão e estudo da terminologia e fisiopatologia. 1999; 45(1):86-92.
  24. Silva MNP. Síndrome da anorexia-caquexia em portadores de câncer. Revista brasileira de cancerologia, v. 52, n. 1, p. 59-77, jan./ out, 2006.
  25. Xavier H. et al. Relação do consumo de glutamina na melhora do trato gastrointestinal – revisão sistemática. Revista Brasileira de Obesidade, Nutrição e Emagrecimento, São Paulo, v. 3, n. 18, p. 504-512, nov./dez., 2009.
  26. Fillmann H. et al. Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappa B pathway in an experimental model of colitis in the rat. Toxicology, v. 236, n. 3, p. 217-26, 2007.
  27. Medina MA. et al. Relevance of glutamine metabolism to tumor cell growth. Mol. Cell. Biochem, n. 113, p. 1-15, jan./abr., 1992.
  28. Mazurek S, Boschek CB, Eigenbrodt E. The role of phosphor metabolites in cell proliferation, energy metabolism, and tumor therapy. J. Bioenerg. & biomemb, v. 29, n. 4, p. 315-30, abr./jun.1997.
  29. Santos RGC. A ação da glutamina no processo de translocação bacteriana em modelo experimental de obstrução intestinal em camundongos. Tese (Doutorado em Farmácia) - Faculdade de farmácia da UFMG, Minas Gerais, 2007.
  30. Farias J. et al. Oxidative stress parameters in women with breast cancer undergoing neoadjuvant chemotherapy and treated with nutraceutical doses of oral glutamie. Acta Cirúrgica Brasileira, São Paulo, Suppl. 1), v. 26, p. 82-87, 2011.

How to Cite

Cavalcante, D. E. C., Pinto, A. C., Araújo, E. A., Cabral, F. M., Santos, J. M., & Costa, K. V. (2021). The benefits of glutamine in the treatment of patients with cancer. International Journal of Nutrology, 14(3). https://doi.org/10.54448/ijn2136